Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Extracellular fluid compartment expansion refers to an increase in the volume of fluid outside body cells, primarily in the interstitial and intravascular spaces. This process occurs due to various physiological or pathological causes, such as excessive intravenous fluid administration, renal impairment, heart failure, or liver disease. Expansion of the extracellular compartment can lead to clinical conditions like edema and volume overload, requiring medical intervention. This phenomenon is regulated by factors such as hydrostatic pressure, osmotic gradients, and hormonal controls, and it plays a central role in maintaining tissue perfusion and electrolyte balance. Therapeutic strategies target the underlying mechanisms to restore normal fluid compartments and prevent complications.
Alteration of renal sodium and water reabsorption, Osmotic shifts between compartments, Modification of capillary and hydrostatic pressures
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Extracellular fluid compartment expansion.